- Home
- KROS vs FFWM Comparison
KROS vs FFWM Comparison
Compare KROS & FFWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- FFWM
- Stock Information
- Founded
- KROS 2015
- FFWM 1990
- Country
- KROS United States
- FFWM United States
- Employees
- KROS N/A
- FFWM N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- FFWM Major Banks
- Sector
- KROS Health Care
- FFWM Finance
- Exchange
- KROS Nasdaq
- FFWM Nasdaq
- Market Cap
- KROS 589.8M
- FFWM 510.5M
- IPO Year
- KROS 2020
- FFWM 2014
- Fundamental
- Price
- KROS $11.41
- FFWM $6.40
- Analyst Decision
- KROS Buy
- FFWM Buy
- Analyst Count
- KROS 11
- FFWM 4
- Target Price
- KROS $45.33
- FFWM $6.75
- AVG Volume (30 Days)
- KROS 2.0M
- FFWM 486.5K
- Earning Date
- KROS 02-26-2025
- FFWM 01-30-2025
- Dividend Yield
- KROS N/A
- FFWM 0.31%
- EPS Growth
- KROS N/A
- FFWM N/A
- EPS
- KROS N/A
- FFWM N/A
- Revenue
- KROS $651,000.00
- FFWM $108,182,000.00
- Revenue This Year
- KROS $303.27
- FFWM N/A
- Revenue Next Year
- KROS N/A
- FFWM $31.36
- P/E Ratio
- KROS N/A
- FFWM N/A
- Revenue Growth
- KROS 8037.50
- FFWM N/A
- 52 Week Low
- KROS $9.78
- FFWM $4.84
- 52 Week High
- KROS $73.00
- FFWM $11.47
- Technical
- Relative Strength Index (RSI)
- KROS 22.44
- FFWM 50.03
- Support Level
- KROS $9.78
- FFWM $6.00
- Resistance Level
- KROS $11.63
- FFWM $6.38
- Average True Range (ATR)
- KROS 0.89
- FFWM 0.27
- MACD
- KROS 1.07
- FFWM 0.09
- Stochastic Oscillator
- KROS 23.61
- FFWM 94.38
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About FFWM First Foundation Inc.
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.